Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 11
Submit an article Journal homepage
2,455
Views
7
CrossRef citations to date
0
Altmetric
Neurology

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Shonda A. Fostera Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
,
Chi-Chang Chenb IQVIA, Plymouth Meeting, PA, USA
,
Yao Dingb IQVIA, Plymouth Meeting, PA, USA
,
Oksana Masona Eli Lilly and Company, Indianapolis, IN, USA
,
Catherine B. McGuinessb IQVIA, Plymouth Meeting, PA, USA
,
Paula Morrowa Eli Lilly and Company, Indianapolis, IN, USA
,
Wenyu Yea Eli Lilly and Company, Indianapolis, IN, USA
,
Rolin L. Wadeb IQVIA, Plymouth Meeting, PA, USA
,
Timothy R. Smithc StudyMetrix, LLC, St. Peters, MO, USA
&
Shivang Joshid DENT Neurologic Institute, Amherst, NY, USA
 show all
Pages 1356-1364 | Received 06 Apr 2020, Accepted 06 Aug 2020, Published online: 12 Sep 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pamela Vo, Elyse Swallow, Eric Wu, Miriam L. Zichlin, Noah Katcher, Monika Maier-Peuschel, Mariantonietta Naclerio, Daniela Ritrovato, Santosh Tiwari, Parth Joshi & Matias Ferraris. (2021) Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain. Journal of Medical Economics 24:1, pages 900-907.
Read now

Articles from other publishers (6)

Gabriella Juhasz, Kinga Gecse & Daniel Baksa. (2023) Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response. Pharmacology & Therapeutics 250, pages 108523.
Crossref
Orla Flynn, Brona M. Fullen & Catherine Blake. (2022) Migraine in university students: A systematic review and meta‐analysis. European Journal of Pain 27:1, pages 14-43.
Crossref
Taoufik Alsaadi, Suzan Noori, Razmig Varakian, Saly Youssef & AbuBaker Almadani. (2022) Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE. BMC Neurology 22:1.
Crossref
Christopher Gottschalk, Anirban Basu, Andrew Blumenfeld, Bradley Torphy, Michael J Marmura, Jelena M Pavlovic, Paula K Dumas, Nim Lalvani & Dawn C Buse. (2022) The importance of an early onset of migraine preventive disease control: A roundtable discussion. Cephalalgia Reports 5, pages 251581632211345.
Crossref
Peter Petschner, Daniel Baksa, Gabor Hullam, Dora Torok, Andras Millinghoffer, J. F. William Deakin, Gyorgy Bagdy & Gabriella Juhasz. (2021) A replication study separates polymorphisms behind migraine with and without depression. PLOS ONE 16:12, pages e0261477.
Crossref
Mamoru Shibata, Satoshi Kitagawa, Chunghua Tang, Miyuki Unekawa, Yohei Kayama, Toshihiko Shimizu, Jin Nakahara & Norihiro Suzuki. (2021) Protracted hypomobility in the absence of trigeminal sensitization after cortical spreading depolarization: Relevance to migraine postdrome. Neuroscience Research 172, pages 80-86.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.